Craft and Joshi’s team found that B cells presenting tumor antigens can promote the differentiation of tumor-specific helper CD4+ T cells, producing IL-21, enhancing anti-tumor CD8+ T cell responses, and thereby controlling tumor growth [47]. Here, CD8A is linked to neoplasm.